Literature DB >> 18434232

Smoking and tea consumption delay onset of Parkinson's disease.

Boris Kandinov1, Nir Giladi, Amos D Korczyn.   

Abstract

Cigarette smoking, coffee and tea drinking may protect against Parkinson's disease (PD). These factors were assessed, retrospectively, to measure their effect on the age of PD onset. The study population consisted of 278 consecutive PD patients. Smoking > or =10 pack-years delayed age of PD onset by 3.2 years (p<0.05). Consumption of tea more than 3 cups per day delayed age of motor symptoms onset by 7.7 years (p<0.01). Coffee consumption exceeding 3 cups per day advanced the age of PD onset by 4.8 years (p=0.03). Thus, tea consumption and smoking can delay the age of PD onset, while coffee drinking may have the opposite effect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434232     DOI: 10.1016/j.parkreldis.2008.02.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  26 in total

Review 1.  Tea and health: preventive and therapeutic usefulness in the elderly?

Authors:  Bradley W Bolling; Chung-Yen Oliver Chen; Jeffrey B Blumberg
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

2.  The Therapeutic Implications of Tea Polyphenols Against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD).

Authors:  Zhi Dong Zhou; Shao Ping Xie; Wuan Ting Saw; Patrick Ghim Hoe Ho; Hongyan Wang; Zhou Lei; Zhao Yi; Eng King Tan
Journal:  Cells       Date:  2019-08-16       Impact factor: 6.600

Review 3.  Gait dynamics in Parkinson's disease: common and distinct behavior among stride length, gait variability, and fractal-like scaling.

Authors:  Jeffrey M Hausdorff
Journal:  Chaos       Date:  2009-06       Impact factor: 3.642

4.  Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators.

Authors:  Natalya A Smirnova; Renee E Haskew-Layton; Manuela Basso; Dmitry M Hushpulian; Jimmy B Payappilly; Rachel E Speer; Young-Hoon Ahn; Ilay Rakhman; Philip A Cole; John T Pinto; Rajiv R Ratan; Irina G Gazaryan
Journal:  Chem Biol       Date:  2011-06-24

5.  Gender effect on time to levodopa-induced dyskinesias.

Authors:  Sharon Hassin-Baer; Irena Molchadski; Oren S Cohen; Zeev Nitzan; Lilach Efrati; Olga Tunkel; Evgenia Kozlova; Amos D Korczyn
Journal:  J Neurol       Date:  2011-05-01       Impact factor: 4.849

Review 6.  Novel therapeutic strategies in Parkinson's disease.

Authors:  Peter Klivenyi; Laszlo Vecsei
Journal:  Eur J Clin Pharmacol       Date:  2009-10-16       Impact factor: 2.953

7.  Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration.

Authors:  Ki Sung Kang; Noriko Yamabe; Yujing Wen; Masayuki Fukui; Bao Ting Zhu
Journal:  Brain Res       Date:  2012-12-01       Impact factor: 3.252

Review 8.  Does tea consumption correlate to risk of fracture? A meta-analysis.

Authors:  An Yan; Hao-Hua Zhang; Shang-Quan Wang; Yong Zhao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

9.  Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?

Authors:  Anja Mähler; Silvia Mandel; Mario Lorenz; Urs Ruegg; Erich E Wanker; Michael Boschmann; Friedemann Paul
Journal:  EPMA J       Date:  2013-02-18       Impact factor: 6.543

10.  Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies.

Authors:  Ki Sung Kang; Yujing Wen; Noriko Yamabe; Masayuki Fukui; Stephanie C Bishop; Bao Ting Zhu
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.